221 related articles for article (PubMed ID: 23663085)
1. Severe hypertriglyceridaemia in horses and ponies with endocrine disorders.
Dunkel B; Wilford SA; Parkinson NJ; Ward C; Smith P; Grahame L; Brazil T; Schott HC
Equine Vet J; 2014 Jan; 46(1):118-22. PubMed ID: 23663085
[TBL] [Abstract][Full Text] [Related]
2. Severe hypertriglyceridaemia in clinically ill horses: diagnosis, treatment and outcome.
Dunkel B; McKenzie HC
Equine Vet J; 2003 Sep; 35(6):590-5. PubMed ID: 14515960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
4. Influence of endocrine disease on l-lactate concentrations in blood of ponies.
Dunkel B; Knowles EJ; Chang YM; Menzies-Gow NJ
J Vet Intern Med; 2021 May; 35(3):1582-1588. PubMed ID: 34043845
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia.
Morgan RA; McGowan TW; McGowan CM
Aust Vet J; 2014 Apr; 92(4):101-6. PubMed ID: 24673135
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
de Laat MA; Sillence MN; Reiche DB
J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
[TBL] [Abstract][Full Text] [Related]
7. Blood lactate concentrations in ponies and miniature horses with gastrointestinal disease.
Dunkel B; Kapff JE; Naylor RJ; Boston R
Equine Vet J; 2013 Nov; 45(6):666-70. PubMed ID: 23451985
[TBL] [Abstract][Full Text] [Related]
8. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hypertriglyceridemia and response to treatment with insulin in horses, ponies, and donkeys: 44 cases (1995-2005).
Waitt LH; Cebra CK
J Am Vet Med Assoc; 2009 Apr; 234(7):915-9. PubMed ID: 19335242
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
[TBL] [Abstract][Full Text] [Related]
11. Circannual variation in plasma adrenocorticotropic hormone concentrations and dexamethasone suppression test results in Standardbred horses, Andalusian horses and mixed-breed ponies.
Bamford NJ; Harris PA; Bailey SR
Aust Vet J; 2020 Dec; 98(12):616-621. PubMed ID: 33001453
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses.
McGowan TW; Pinchbeck GP; McGowan CM
Equine Vet J; 2013 Jan; 45(1):74-9. PubMed ID: 22594955
[TBL] [Abstract][Full Text] [Related]
13. Investigation of breed differences in plasma adrenocorticotropic hormone concentrations among healthy horses and ponies.
Bamford NJ; Stewart AJ; El-Hage CM; Bertin FR; Bailey SR
Vet J; 2023; 296-297():105995. PubMed ID: 37207985
[TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
15. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
Rendle DI; Litchfield E; Heller J; Hughes KJ
Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
[TBL] [Abstract][Full Text] [Related]
16. Obesity and obesity-associated metabolic disease conditions in Connemara ponies in Ireland.
Al-Ansari AS; Golding E; Walshe N; Mooney CT; Duggan V
Equine Vet J; 2024 Mar; 56(2):273-280. PubMed ID: 37985219
[TBL] [Abstract][Full Text] [Related]
17. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
[TBL] [Abstract][Full Text] [Related]
18. Field treatment and management of endocrinopathic laminitis in horses and ponies.
Walsh DM
Vet Clin North Am Equine Pract; 2010 Aug; 26(2):379-90. PubMed ID: 20699182
[TBL] [Abstract][Full Text] [Related]
19. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
[TBL] [Abstract][Full Text] [Related]
20. Seasonal and annual influence on insulin and cortisol results from overnight dexamethasone suppression tests in normal ponies and ponies predisposed to laminitis.
Borer-Weir KE; Menzies-Gow NJ; Bailey SR; Harris PA; Elliott J
Equine Vet J; 2013 Nov; 45(6):688-93. PubMed ID: 23521139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
